No insider purchase over the last 90 days. The latest, by 버킷스튜디오, was filed 10 Oct 2023.
INBIOGEN Co., Ltd.: what insiders have been doing
INBIOGEN Co., Ltd. is a Retail company. Its directors and officers file their transactions with DART (FSS). The past year has been quiet: not a single insider filing for INBIOGEN Co., Ltd. The previous disclosure was published on 7 January 2025.
Looking back to 2021, when coverage begins, insiders filed 13 purchases and 20 sales.
Elsewhere in the same sector, our signals recently picked up insider purchases at Rusta AB (publ) and Puuilo Oyj. Source: insider filings from DART (FSS). Past trades are no guide to future returns.
Who traded when
BuySaleSince the insiders bought
- -51.2%Entry ₩19,120 · Close at T+365 ₩9,340
- -83.8%Entry ₩60,800 · Close at T+365 ₩9,860
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- Other0DART
- 150,581,837 sharesKRXDART:20250107000454
- 150,549,537 sharesShareKRXDART:20231010000662Canonical exit: 22 Dec 2023 (T+90)
- 32,300 sharesShareKRXDART:20231010000136Canonical exit: 22 Dec 2023 (T+90)
- ●Executives0DART
- 150,581,837 sharesKRXDART:20230605000107
- 234,558 sharesShareKRXDART:20230605000104
- 150,581,837 sharesKRXDART:20230504000524
- 150,581,837 sharesKRXDART:20230504000757
- 6,236,559 sharesShareKRXDART:20230504000543Canonical exit: 25 Jul 2023 (T+90)
- 10,659,994 sharesShareKRXDART:20230327000904Canonical exit: 24 Jun 2023 (T+90)
- 150,581,837 sharesKRXDART:20230327000895
- ●Executives0DART
- 16,135,573 shares@ ₩843.00100.0% of flowShareKRXDART:20221125000514Canonical exit: 17 Feb 2023 (T+90)
- 150,581,837 sharesKRXDART:20221125000506
- 35,379,263 sharesShareKRXDART:20221104000346Canonical exit: 27 Jan 2023 (T+90)
- 150,581,837 sharesKRXDART:20221104000336
- 23,799,277 sharesShareKRXDART:20221028000395Canonical exit: 24 Jan 2023 (T+90)
- 150,581,837 sharesKRXDART:20221028000389
- 8,019,754 sharesShareKRXDART:20221007000485Canonical exit: 28 Dec 2022 (T+90)
- 150,581,837 sharesKRXDART:20221007000477
- 3,920,009 sharesShareKRXDART:20220708000617Canonical exit: 29 Sept 2022 (T+90)
- 150,581,837 sharesKRXDART:20220708000612
- 8,539,580 sharesShareKRXDART:20220701000443Canonical exit: 24 Sept 2022 (T+90)
- 150,581,837 sharesKRXDART:20220701000435
25 of 39 declarations
About INBIOGEN Co., Ltd.
Inbiozen is a company listed on the XKRX stock exchange, specializing in the biopharmaceutical sector. It focuses on developing innovative treatments for various diseases.
